| 前收市價 | 37.81 |
| 開市 | 37.73 |
| 買盤 | 38.05 x 200 |
| 賣出價 | 38.20 x 100 |
| 今日波幅 | 37.73 - 38.65 |
| 52 週波幅 | 29.85 - 45.00 |
| 成交量 | |
| 平均成交量 | 1,079,979 |
| 市值 | 4.846B |
| Beta 值 (5 年，每月) | 1.25 |
| 市盈率 (最近 12 個月) | 18.16 |
| 每股盈利 (最近 12 個月) | 2.10 |
| 業績公佈日 | 2024年5月07日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 51.11 |
ZacksHalozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
Halozyme Therapeutics (HALO) could produce exceptional returns because of its solid growth attributes.
ZacksHalozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
Halozyme Therapeutics (HALO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksAre You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
